Understanding your result gives you a personalized starting point for targeted lifestyle, dietary, and supplement strategies grounded in your unique biology
An initial analysis of the FDA adverse event reporting system (FAERS) data demonstrated no consistent trends in DKA with SGLT2i use over time [39], however an alternative cohort study of 50,220 individuals with type 2 diabetes showed the highest risk of DKA shortly after SGLT2i initiation, which subsequently reduced with time [40]
For example, portion control becomes easier without persistent internal resistance
Furthermore, Dihexa remains a valuable material for laboratory programs focused on compound characterization and analytical investigation
[42] Subsequent analyses have clarified that this early worsening of pre-existing retinopathy is a secondary effect caused by the rapid and robust drop in blood glucose levels, rather than a direct toxic effect of semaglutide on the eyes